SARS-CoV-2 Glycosylation Profiling Service Now Available at CD BioGlyco
CD BioGlyco, a biotechnology company that offers a full range of glycobiology-related products, analysis, custom synthesis, and design to help advance glycobiology research, now provides customers with comprehensive and accurate viral glycomics information to speed up the development of vaccines and other therapeutic agents during this COVID-19 pandemic.
The US FDA has approved Pfizer and Moderna's two vaccines for sale in the US market. The scientific community is still trying to understand the virus in many ways and compile useful data. The virus uses the spike protein (S protein) to bind angiotensin-converting enzyme 2 (ACE-2) to cause infection. S protein is a highly glycosylated protein with 22 N-linked and 3 O-linked glycosylation sites. It is a key protein that affects virus infection and vaccine preparation. Therefore, it has become the focus of attention in academia and industry.
To help scientists around the world better study SARS-CoV-2, CD BioGlyco integrates its most advanced technology platforms and doe its best to promote coronavirus research. The following services are now available at CD BioGlyco for customers to choose from:
*Gene sequence of SARS-CoV-2 related proteins, including spike protein, nucleocapsid protein, papain-like protease, 3CL protease, and various receptors in host cells and other related proteins.
*A variety of glycoengineered expression systems, covering HEK293, CHO, BHK, SF21, etc., to express SARS-CoV-2 related proteins based on customers' needs.
*Comprehensive glycomics analysis platform to systematically analyze the coronavirus-related glycoproteins of interest, including glycosylation profiling, comparative characterization (changes in the propagation process and the comparison with the glycosylation characteristics of SARS-CoV, etc.), to provide the necessary basis for vaccine development.
* Lectin-based development services
According to the official speaker from CD BioGlyco, their service can be utilized for vaccine development, detection kit development, virology research, tools development for microarray, immunoassay, and virus purification from whole blood, and development of biomarkers to predict disease severity.
“We are committed to developing various technology platforms to help scientists around the world to explore the coronavirus and promote the global vaccine development process. With our professional teams and ultra-high precision instruments, we are confident to provide high-quality viral glycomics service to you all.” commented Anna, one of the marketing staff at CD BioGlyco.
To know more about the SARS-CoV-2 Glycosylation Profiling service at CD BioGlyco, please visit https://www.bioglyco.com/sars-cov-2-glycosylation-profiling.html.
-
Most popular related searches
Related news
-
CD Genomics RNA Diversifies Its RNA Service Portfolio by Adding Whole Transcriptome Sequencing
RNA Solutions is the platform that offers services on the revolutionizing study of RNA, targeting both coding and non-coding RNAs of different physiological functions. The scientists at CD Genomics are ready to help detect various types of RNA via meticulous and integrative approaches. To further enrich its service types, the company recently announced to add Whole Transcriptome Sequencing to its offerings. Now scientists and researchers worldwide can easily obtain whole transcriptome sequencing needed in their...
-
The MALDI-Imaging Lipidomics Service Is Now Available Through Lipidomics Platform
As a division of Creative Proteomics, Lipidomics is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnology and pharmaceutical companies. The company has recently announced the fully-developed MALDI-Imaging Lipidomics Service to research the distribution of lipids in tissues. Lipidomics MALDI imaging mass spectrometry (MALDI-IMS) is a very powerful tool for studying lipid distribution in tissues. MALDI is an ion source that is very...
-
Creative BioMart Provides a Wide Range of Centromere Proteins for Research Use
Creative BioMart, a world leading biotech company specialized in providing quality protein products and services to customers all over the world now provides a wide selection of centromere proteins for cancer research. Centromeres are specialized DNA sequences in chromosomes, which hold two daughter chromatids together. Centromeres represent a contractile region of the chromosome in which two identical sister chromatids are most in contact. The centromere is the attachment point of the kinetochore, a highly...
-
CD Genomics Provides Integration Analysis of Whole-Genome Bisulfite and RNA Sequencing for Biomarker Research
CD Genomics, a genomics services company, has become one of the top providers in genomic research, devoting to providing reliable services to pharmaceutical and biotech companies as well as academia and government agencies. CD Genomics provides a wide range of services such as genome sequencing, RNA sequencing, epigenomics sequencing, genotyping, as well as integrated portfolios of multiple sequencing services. Integration analysis of multiple sequencing data provides a broader view of the genomics research,...
-
MicrobioSeq Releases SMRT-Based Transcriptomics Analysis Service to Boost Your Discovery
MicrobioSeq represents the microbial genomics division of CD Genomics headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation in providing reliable sequencing, genotyping, microarray, and bioinformatics services. Nowadays, the company announced SMRT-based transcriptomics analysis, which is useful to identify novel transcript isoforms, fusion gene expression, and alternative splicing events, and also improve genome annotation. Transcriptomics enables genome-wide analysis...
Customer comments
No comments were found for SARS-CoV-2 Glycosylation Profiling Service Now Available at CD BioGlyco. Be the first to comment!